News
According to market observers, unlisted shares of Dev Accelerator Ltd are currently trading at Rs 67 against the upper IPO ...
TipRanks on MSN
Microbot Medical Secures $25.2M in New Funding Round
The most recent analyst rating on (MBOT) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on Microbot Medical stock, see the MBOT Stock Forecast page.
A good trading simulator should allow you to practise across a wide range of asset classes. These may include stocks, forex, commodities, indices, or even cryptocurrencies. The more options available, ...
Prediction markets are reshaping forecasting by blending collective wisdom, finance, and regulation into a new pillar of DeFi ...
Robo.ai Inc. (NASDAQ: AIIO) announces strategic investment in Arkreen through DePIN technology firm aitos.io, connecting AI ...
There are no fees to use the basic version of the platform. Robinhood's premium subscription, Robinhood Gold, costs just $5 a ...
From tested litter boxes to our favorite luggage, these are the 24 top products Forbes Vetted readers shopped in August.
Shringar House of Mangalsutra IPO allotment details are due soon, with the issue oversubscribed 60.29x. Investors can verify ...
Is Nvidia a buy or sell?… a new tailwind behind uranium/nuclear stocks… the U.S. needs to fix a strategic chokehold… Musk’s $1B bet on robots… Jonathan Rose’s LYFT trade keeps climbing VIEW IN BROWSER ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results